Search results
Analysts Set Revvity, Inc. (NYSE:RVTY) Target Price at $117.92
ETF DAILY NEWS· 8 hours agoShares of Revvity, Inc. (NYSE:RVTY – Get Free Report) have earned an average rating of “Moderate Buy” from the fourteen brokerages that are presently covering the company, MarketBeat Ratings ...
Pax Dei launches in Early Access on June 18
Gematsu· 3 days agoSocial sandbox massively multiplayer online game Pax Dei will launch in Early Access for PC via Steam and the Pax Dei Launcher on June 18, publisher New...
Alpha Teknova (TKNO) Upgraded to Buy: What Does It Mean for the Stock?
Zacks via Yahoo Finance· 19 hours agoYou can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here >>>>. Earnings...
Scientists make discovery that could act as 'energy drink' for aging vehicle batteries: 'Very...
The Cool Down via Yahoo News· 2 days agoIt works like this: In simple terms, standard lithium-based batteries lose their charging capacity...
InDevR and Sino Biological Team Up to Deliver Multiplexed Analytical Solutions for mRNA Vaccine and...
Digital Journal· 2 days agoThrough this partnership, Sino Biological's catalog...
QIAGEN's (QGEN) New Launch Expands US Syndromic Testing Menu
Zacks via Yahoo Finance· 2 days agoBoth panels are available as cost-efficient, single-use cartridges that slot easily into the...
Bioz and Quantabio Launch AI-Driven Citation Widgets to Provide Researchers With Real-Time...
Digital Journal· 2 days agoWith over 20,000 citations in the scientific literature, this partnership aims to highlight Quantabio's significant impact on scientific research. Bioz Pro Badge...
Detergent-resistant α-amylase derived from Anoxybacillus karvacharensis K1 and its production based...
Nature· 4 days agoIn the field of biotechnology, the utilization of agro-industrial waste for generating high-value products, such as microbial biomass and enzymes, holds significant importance. This study aimed ...
JD Supra: Key Takeaways from FDA’s Final Rule on Laboratory-Developed Tests
JD Supra· 16 hours agoThe US Food and Drug Administration (FDA) on April 29, 2024 announced its Final Rule on laboratory-developed tests (LDTs). This marks the beginning of the end of FDA’s broad and long-established ...
MYCT1 controls environmental sensing in human haematopoietic stem cells - Nature
Nature· 2 days agoMYCT1 is identified as a crucial regulator of cellular properties essential for the stemness of human haematopoietic stem cells, a finding that may help improve successful in vitro expansion of these cells for therapeutics.